NextCure, Inc. — Director's Dealing 2020

Jul 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2020-07-14

Reporting Person: Heller Kevin N. (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-14	Common Stock	M	27229	$1.77	Acquired	49011	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-14	Employee Stock Option (Right to Buy)	$1.77	M	27229	Disposed	2028-08-27	Common Stock (27229)	Direct

Footnotes

F1: One fourth of the option vested on April 2, 2019. The remainder vests in 36 monthly installments beginning on May 2, 2019.